Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/14/2020 09/15/2020 09/16/2020 09/17/2020 09/18/2020 Date
90.49(c) 90.91(c) 89.78(c) 89.63(c) 90.11(c) Last
5 212 480 3 851 321 6 307 956 5 604 683 9 996 405 Volume
+0.88% +0.46% -1.24% -0.17% +0.54% Change
More quotes
Financials (USD)
Sales 2020 45 502 M - -
Net income 2020 10 949 M - -
Net Debt 2020 71 972 M - -
P/E ratio 2020 16,3x
Yield 2020 5,42%
Sales 2021 53 597 M - -
Net income 2021 15 922 M - -
Net Debt 2021 60 538 M - -
P/E ratio 2021 10,4x
Yield 2021 5,76%
Capitalization 159 B 159 B -
EV / Sales 2020 5,08x
EV / Sales 2021 4,10x
Nbr of Employees 47 000
Free-Float 98,5%
More Financials
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Sales are distributed geographically as follows: the United States (71.9%), Japan (3.7%), Germany... 
Sector
Pharmaceuticals
Calendar
10/14Ex-dividend day for
More about the company
Notations Surperformance© of AbbVie Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ABBVIE INC.
09/17ABBVIE : Malin Akerman Joins CoolSculpting and CoolTone as U.S. Ambassador for t..
AQ
09/17South Korea approves Phase 2/3 trials of Celltrion COVID-19 antibody drug
RE
09/16ABBVIE : Malin Akerman Joins CoolSculpting® and CoolTone™ as U.S. Ambassad..
PR
09/15ABBVIE : Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiativ..
AQ
09/14ABBVIE : to Present New Data from 18 Abstracts at the International Congress of ..
AQ
09/14ABBVIE : Declares Quarterly Dividend
AQ
09/14ABBVIE : Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiativ..
PR
09/11ABBVIE : to Present New Data From 18 Abstracts at the International Congress of ..
PR
09/11ABBVIE : Declares Quarterly Dividend
PR
09/04AbbVie to develop and sell China-based I-Mab's cancer drug
RE
09/04I MAB : AbbVie to Collaborate on Cancer Treatment Lemzoparlimab
DJ
09/03ABBVIE : to Present at the Morgan Stanley Healthcare Conference
PR
08/26MORPHIC : Announces that abbvie exercises license option to v6 integrin inhibito..
AQ
08/26ABBVIE : Submits Regulatory Application to FDA for RINVOQ for the Treatment of A..
AQ
08/25ABBVIE : Seeks FDA OK for Rinvoq in Adults With Active Ankylosing Spondylitis
DJ
More news
News in other languages on ABBVIE INC.
09/04Les valeurs à suivre aujourd'hui à Wall Street Vendredi 4 septembre 2020
09/04ABBVIE : partenariat avec le chinois I-MAB
09/04WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
07/31Les valeurs à suivre aujourd'hui à Wall Street Vendredi 31 juillet 2020
07/31ABBVIE : bat le consensus au second trimestre
More news
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 109,56 $
Last Close Price 90,11 $
Spread / Highest target 40,9%
Spread / Average Target 21,6%
Spread / Lowest Target 6,54%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.1.77%159 029
JOHNSON & JOHNSON2.27%387 473
ROCHE HOLDING AG7.29%316 308
MERCK & CO., INC.-5.65%216 604
PFIZER, INC.-6.02%204 604
NOVARTIS AG-10.45%199 361